scholarly article | Q13442814 |
P50 | author | Magdalena Götz | Q1883780 |
Hajime Hirase | Q55175553 | ||
Junichi Yoshida | Q59563715 | ||
Kenji F. Tanaka | Q38589772 | ||
P2093 | author name string | Masatoshi Nomura | |
Norio Takata | |||
Masanobu Kano | |||
Ryoichi Takayanagi | |||
Kohichi Tanaka | |||
Miho Soma | |||
Yukiko Ito | |||
Hidenori Aizawa | |||
Asami Tanimura | |||
Tomomi Aida | |||
Wanpeng Cui | |||
Ning Bai | |||
Michiko Yanagisawa | |||
Terumi Nagai | |||
Yusuke Iino | |||
P2860 | cites work | The role of glutamate signaling in the pathogenesis and treatment of obsessive-compulsive disorder | Q24605193 |
Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice. | Q24648260 | ||
Sequential super-stereotypy of an instinctive fixed action pattern in hyper-dopaminergic mutant mice: a model of obsessive compulsive disorder and Tourette's | Q24797858 | ||
Mapping autism risk loci using genetic linkage and chromosomal rearrangements | Q27315912 | ||
Motor discoordination and increased susceptibility to cerebellar injury in GLAST mutant mice | Q28508015 | ||
Slitrk5 deficiency impairs corticostriatal circuitry and leads to obsessive-compulsive-like behaviors in mice | Q28511908 | ||
Protocadherin 17 regulates presynaptic assembly in topographic corticobasal Ganglia circuits | Q28589554 | ||
Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1 | Q28592689 | ||
Model of autism: increased ratio of excitation/inhibition in key neural systems | Q29547530 | ||
A robust and high-throughput Cre reporting and characterization system for the whole mouse brain | Q29616609 | ||
Reduced alcohol intake and reward associated with impaired endocannabinoid signaling in mice with a deletion of the glutamate transporter GLAST. | Q30451627 | ||
Assessment of glutamate transporter GLAST (EAAT1)-deficient mice for phenotypes relevant to the negative and executive/cognitive symptoms of schizophrenia | Q30465586 | ||
Assessing the validity of current mouse genetic models of obsessive-compulsive disorder | Q30482891 | ||
VGLUT2-dependent sensory neurons in the TRPV1 population regulate pain and itch. | Q30498423 | ||
Local potentiation of excitatory synapses by serotonin and its alteration in rodent models of depression | Q30538101 | ||
Excitatory/inhibitory synaptic imbalance leads to hippocampal hyperexcitability in mouse models of tuberous sclerosis | Q30540852 | ||
Repeated cortico-striatal stimulation generates persistent OCD-like behavior | Q30574071 | ||
Genetic and functional studies of a missense variant in a glutamate transporter, SLC1A3, in Tourette syndrome | Q83202734 | ||
Tourette's syndrome | Q87287270 | ||
Recent advances in Tourette syndrome research | Q33232326 | ||
A genomic atlas of mouse hypothalamic development | Q33795412 | ||
Glutamate transporter EAAC-1-deficient mice develop dicarboxylic aminoaciduria and behavioral abnormalities but no neurodegeneration | Q33886917 | ||
Evidence-based pharmacotherapy of obsessive-compulsive disorder | Q34245428 | ||
Overstimulation of NMDA receptors impairs early brain development in vivo | Q34273724 | ||
Using animal models to develop therapeutics for Tourette Syndrome | Q34428098 | ||
From the Cover: Indispensability of the glutamate transporters GLAST and GLT1 to brain development | Q34882613 | ||
Neurobiology of obsessive-compulsive disorder: insights into neural circuitry dysfunction through mouse genetics | Q35341623 | ||
Astrocytes and disease: a neurodevelopmental perspective | Q35945056 | ||
Mg2+ imparts NMDA receptor subtype selectivity to the Alzheimer's drug memantine | Q37184807 | ||
Loss of glial glutamate and aspartate transporter (excitatory amino acid transporter 1) causes locomotor hyperactivity and exaggerated responses to psychotomimetics: rescue by haloperidol and metabotropic glutamate 2/3 agonist | Q37226649 | ||
The neurobiology of repetitive behavior: …and men. | Q37691915 | ||
Glutamate mediated signaling in the pathophysiology of autism spectrum disorders | Q37901148 | ||
Animal models recapitulating the multifactorial origin of Tourette syndrome. | Q38167908 | ||
Neurobehavioral aspects, pathophysiology, and management of Tourette syndrome | Q38224622 | ||
Inducible gene deletion in astroglia and radial glia--a valuable tool for functional and lineage analysis | Q40284616 | ||
A transgenic model of comorbid Tourette's syndrome and obsessive-compulsive disorder circuitry | Q42681259 | ||
Glutamatergic modulatory therapy for Tourette syndrome | Q43214831 | ||
Effects of nicotine on head-shakes and tryptophan metabolites | Q43555252 | ||
Memantine add-on in moderate to severe obsessive-compulsive disorder: randomized double-blind placebo-controlled study. | Q45348417 | ||
Diverse and often opposite behavioural effects of NMDA receptor antagonists in rats: implications for "NMDA antagonist modelling" of schizophrenia. | Q46022286 | ||
Behavioral characterization of GLT1 (+/-) mice as a model of mild glutamatergic hyperfunction. | Q46681661 | ||
Glial dysfunction in the mouse habenula causes depressive-like behaviors and sleep disturbance. | Q47700855 | ||
Differential effects of NMDA receptor antagonists at lower and higher doses on basal gamma band oscillation power in rat cortical electroencephalograms | Q47860614 | ||
Bergmann glial AMPA receptors are required for fine motor coordination | Q48449564 | ||
Opposing role of NMDA receptor GluN2B and GluN2D in somatosensory development and maturation. | Q48579924 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International | Q42553662 |
P6216 | copyright status | copyrighted | Q50423863 |
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | astrocyte | Q502961 |
P304 | page(s) | 1569-1579 | |
P577 | publication date | 2015-02-09 | |
P1433 | published in | Neuropsychopharmacology | Q2261280 |
P1476 | title | Astroglial glutamate transporter deficiency increases synaptic excitability and leads to pathological repetitive behaviors in mice | |
P478 | volume | 40 |
Q26783129 | Activity-Dependent Plasticity of Astroglial Potassium and Glutamate Clearance |
Q26752605 | Addressing the Complexity of Tourette's Syndrome through the Use of Animal Models |
Q39923469 | Astrocytes gate Hebbian synaptic plasticity in the striatum. |
Q94544533 | Astrocytic Glutamate Transporter 1 (GLT1) Deficiency Reduces Anxiety- and Depression-Like Behaviors in Mice |
Q59128381 | Astrocytic Regulation of Glutamate Transmission in Schizophrenia |
Q47680320 | Astroglial correlates of neuropsychiatric disease: From astrocytopathy to astrogliosis |
Q47933224 | Calpain-Dependent Degradation of Nucleoporins Contributes to Motor Neuron Death in a Mouse Model of Chronic Excitotoxicity. |
Q35552238 | Cloning-free CRISPR/Cas system facilitates functional cassette knock-in in mice. |
Q64063761 | Control of Long-Term Plasticity by Glutamate Transporters |
Q97522709 | Deciphering the star codings: astrocyte manipulation alters mouse behavior |
Q90573489 | Divergent roles of astrocytic versus neuronal EAAT2 deficiency on cognition and overlap with aging and Alzheimer's molecular signatures |
Q36539354 | Do glia drive synaptic and cognitive impairment in disease? |
Q26741939 | Excitation/Inhibition Imbalance in Animal Models of Autism Spectrum Disorders |
Q38478361 | GLAST But Not Least--Distribution, Function, Genetics and Epigenetics of L-Glutamate Transport in Brain--Focus on GLAST/EAAT1. |
Q34546043 | Gene cassette knock-in in mammalian cells and zygotes by enhanced MMEJ |
Q91834712 | Genetic mouse models of migraine |
Q90272845 | Genetic targeting of astrocytes to combat neurodegenerative disease |
Q50420515 | Glia Modulate a Neuronal Circuit for Locomotion Suppression during Sleep in C. elegans |
Q96681646 | Glial glutamate transporter GLT-1 determines susceptibility to spreading depression in the mouse cerebral cortex |
Q46461702 | Glutamate Genetics in Obsessive-Compulsive Disorder: A Review |
Q64097537 | Glutamate spillover in C. elegans triggers repetitive behavior through presynaptic activation of MGL-2/mGluR5 |
Q55505650 | Glutamate transporters, EAAT1 and EAAT2, are potentially important in the pathophysiology and treatment of schizophrenia and affective disorders. |
Q90285639 | How can preclinical mouse models be used to gain insight into prefrontal cortex dysfunction in obsessive-compulsive disorder? |
Q64450655 | Loss of cerebellar glutamate transporters EAAT4 and GLAST differentially affects the spontaneous firing pattern and survival of Purkinje cells |
Q49591645 | Lost in translation? A critical look at the role that animal models of obsessive compulsive disorder play in current drug discovery strategies |
Q38459199 | Molecular approaches for manipulating astrocytic signaling in vivo. |
Q36825003 | Neurobiology of rodent self-grooming and its value for translational neuroscience |
Q41711411 | Neurochemical and behavioral characterization of neuronal glutamate transporter EAAT3 heterozygous mice. |
Q42360046 | Neuron-glia cross talk revealed in reverberating networks by simultaneous extracellular recording of spikes and astrocytes' glutamate transporter and K+ currents. |
Q39028166 | Pediatric Traumatic Brain Injury and Autism: Elucidating Shared Mechanisms |
Q91952589 | Persistent increase in ventral hippocampal long-term potentiation by juvenile stress: A role for astrocytic glutamine synthetase |
Q26765084 | Recent Advance in the Relationship between Excitatory Amino Acid Transporters and Parkinson's Disease |
Q88555567 | Region-specific deletions of the glutamate transporter GLT1 differentially affect nerve injury-induced neuropathic pain in mice |
Q47928721 | Region-specific deletions of the glutamate transporter GLT1 differentially affect seizure activity and neurodegeneration in mice |
Q91633422 | Spatial memory formation requires netrin-1 expression by neurons in the adult mammalian brain |
Q55291849 | Structure-Function Relationship of Transporters in the Glutamate-Glutamine Cycle of the Central Nervous System. |
Q37444933 | Synaptic Actin Dysregulation, a Convergent Mechanism of Mental Disorders? |
Q37220495 | Valproic Acid and Other HDAC Inhibitors Upregulate FGF21 Gene Expression and Promote Process Elongation in Glia by Inhibiting HDAC2 and 3 |
Search more.